Kezar Life Sciences, Inc.
Kezar Life Sciences is developing innovative protein-targeting approaches to treat chronic diseases. They focus on regulating cellular function through selective protein inhibition. A key product is Zetomipzomib (KZR-616) for autoimmune hepatitis. The company aims to improve treatment outcomes.
Registre Officiel
Dernière vérification: 1/2/2026
Analyse Qualité IA
Détails du Score de Confiance
Liens Rapides
Points forts du site
🌟 Entreprises similaires de confiance
Context Therapeutics Inc.
Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.
AGENUS INC
Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.
Sigyn Therapeutics, Inc.
Sigyn Therapeutics develops dialysis-like therapies for cardiovascular disease and cancer. Their therapies are designed to improve patient quality of life. Key products include CardioDialysis™ for cardiovascular disease, and ImmunePrep™, ChemoPrep™ and ChemoPure™ for cancer therapy.